Global Attention Deficit Hyperactivity Disorder Market Growth (Status and Outlook) 2024-2030

2024

Global Attention Deficit Hyperactivity Disorder Market Growth (Status and Outlook) 2024-2030

Name: Global Attention Deficit Hyperactivity Disorder Market Growth (Status and Outlook) 2024-2030
Brand: Bonafide Research
SKU: 95001299
Price: 3450 USD
Availability: InStock
Rating: 5 (13.9 reviews)

The global ADHD market is valued at US$ 11.97 billion in 2024, driven by increasing diagnosis and treatment of ADHD in children and adults.

Bonafide Trust
09-09-2024
Pages : 87
Figures : 79
Tables : 95
Region : Global
Category : Lifescience & Healthcare
Pharmaceutical

Schedule a Call

Buy Now Get Free sample

Request new version

Request for updated version of the report at the same price

Order Now

The global Attention Deficit Hyperactivity Disorder (ADHD) market is experiencing substantial growth as awareness surrounding ADHD increases and the demand for effective treatments rises. ADHD, a neurodevelopmental disorder characterized by symptoms such as inattention, hyperactivity, and impulsivity, affects both children and adults, with diagnoses often occurring in childhood. The global prevalence of ADHD is on the rise, driven by factors such as improved diagnostic tools, greater awareness among healthcare professionals and parents, and expanding access to healthcare services. As the condition is increasingly recognized, there is a growing need for interventions that can help manage the symptoms and improve quality of life for individuals affected by ADHD. The market for ADHD treatment is driven primarily by the pharmaceutical segment, which includes stimulant medications such as methylphenidate and amphetamines, as well as non-stimulant medications like atomoxetine. Additionally, behavioral therapies and cognitive interventions are becoming more common as part of a comprehensive treatment approach. Governments and health organizations are investing in initiatives to enhance ADHD awareness and promote early diagnosis, further fueling market growth. The rising adoption of telemedicine and digital health tools for ADHD management has also contributed to the expanding market, offering patients convenient and accessible options for treatment and monitoring. Moreover, the increasing demand for personalized treatment approaches, including tailored medications and therapies based on genetic and behavioral profiles, is pushing the boundaries of the ADHD market, encouraging pharmaceutical companies to develop innovative solutions that cater to individual needs.

According to Publisher, , the global Attention Deficit Hyperactivity Disorder market size was valued at US$ 11970 million in 2024. With growing demand in downstream market, the Attention Deficit Hyperactivity Disorder is forecast to a readjusted size of US$ 15160 million by 2030 with a CAGR of 3.4% during review period. The pharmaceutical segment is the largest contributor to the global ADHD market, with stimulant medications dominating the treatment landscape. Stimulants, including methylphenidate-based medications (such as Ritalin) and amphetamine-based drugs (like Adderall), are widely prescribed to manage ADHD symptoms by increasing the levels of certain neurotransmitters in the brain, improving attention, focus, and impulse control. These medications have proven to be effective in managing symptoms in both children and adults, making them the first-line treatment for ADHD. However, stimulant medications are not suitable for everyone due to potential side effects, including insomnia, appetite loss, and increased heart rate. As a result, non-stimulant medications such as atomoxetine (Strattera) and guanfacine (Intuniv) are increasingly being used as alternatives for patients who cannot tolerate stimulants or require adjunctive therapy. The growing recognition of the side effects associated with stimulant medications has led to a shift toward non-stimulant treatments, which tend to have a lower risk of abuse and fewer adverse effects. The demand for alternative treatment options is further driving the growth of non-stimulant drugs, as well as the development of novel therapies, including those targeting the underlying neurological causes of ADHD. In addition to pharmaceutical treatments, the ADHD market also includes digital therapeutics and devices, such as neurofeedback systems, that are used to help improve cognitive functioning and attention control. These products are gaining traction as adjunctive therapies to traditional treatments, and their use is expected to grow as more evidence supports their effectiveness in managing ADHD symptoms.

What's Inside a Bonafide Research`s industry report?

A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.

Download Sample

Behavioral therapies and interventions also play a crucial role in the global ADHD market, as they are an essential part of the multimodal treatment approach. Cognitive-behavioral therapy (CBT) and parent training are widely used to help individuals with ADHD develop coping strategies, improve organizational skills, and enhance self-regulation. CBT focuses on altering negative thought patterns and behaviors, helping individuals develop better focus, emotional regulation, and problem-solving skills. Parent training programs are also important as they empower parents with strategies to manage their child’s behavior and support their academic and social development. These therapies are particularly effective when used in combination with medication, as they address the behavioral aspects of ADHD and help individuals improve social interactions, school performance, and family dynamics. Furthermore, school-based interventions, such as academic accommodations and individualized education programs (IEPs), are crucial for managing ADHD in children. The integration of digital platforms and mobile apps that provide behavioral coaching, monitoring, and educational tools has further enhanced the accessibility and effectiveness of ADHD management. These digital solutions offer real-time tracking of symptoms and progress, providing both patients and healthcare providers with valuable insights into treatment effectiveness and areas that need improvement. With the increasing recognition of the importance of non-pharmacological interventions, the market for ADHD therapies and behavioral treatments is expected to expand, particularly as more evidence emerges supporting their role in improving long-term outcomes for individuals with ADHD.

The global ADHD market is segmented based on age groups, treatment types, and distribution channels. By age group, the market is divided into children, adolescents, and adults, with the highest prevalence of ADHD typically observed in children. However, there is a growing recognition of ADHD in adults, leading to an increasing demand for adult-specific treatments and management strategies. The market for ADHD treatment in children remains the largest segment due to the high diagnosis rates and early intervention programs. As awareness of adult ADHD increases, pharmaceutical companies and healthcare providers are increasingly developing treatment plans tailored to adults, who may require different approaches due to the long-term nature of the condition. The market is also segmented by treatment type, with the primary categories being medication, therapy, and digital health solutions. Medication remains the dominant treatment, though therapy and digital interventions are rapidly gaining ground as complementary or alternative options. In terms of distribution channels, the market is segmented into hospitals, clinics, retail pharmacies, and online pharmacies. The growing preference for online pharmacies and telemedicine is driving significant changes in how ADHD treatments are accessed and delivered. As technology continues to advance, the use of digital platforms for monitoring and managing ADHD is expected to play an increasingly important role in the global market, providing patients with greater flexibility and access to personalized treatment solutions. With the continued expansion of the ADHD market, key players are focusing on research and development to introduce more effective, targeted treatments, including those based on genetic profiles and personalized medicine approaches.

Make this report your own

Have queries/questions regarding a report

Take advantage of intelligence tailored to your business objective

Sikandar Kesari

Research Analyst

Don’t pay for what you don’t need. Save 30%

Customise your report by selecting specific countries or regions

Specify Scope Now

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Attention Deficit Hyperactivity Disorder Market Size 2019-2030
2.1.2 Attention Deficit Hyperactivity Disorder Market Size CAGR by Region 2019 VS 2023 VS 2030
2.2 Attention Deficit Hyperactivity Disorder Segment by Type
2.2.1 Stimulants Drugs
2.2.2 Non-stimulants Drugs
2.3 Attention Deficit Hyperactivity Disorder Market Size by Type
2.3.1 Attention Deficit Hyperactivity Disorder Market Size CAGR by Type (2019 VS 2023 VS 2030)
2.3.2 Global Attention Deficit Hyperactivity Disorder Market Size Market Share by Type (2019-2024)
2.4 Attention Deficit Hyperactivity Disorder Segment by Application
2.4.1 Pediatric
2.4.2 Adolescent
2.4.3 Adults
2.5 Attention Deficit Hyperactivity Disorder Market Size by Application
2.5.1 Attention Deficit Hyperactivity Disorder Market Size CAGR by Application (2019 VS 2023 VS 2030)
2.5.2 Global Attention Deficit Hyperactivity Disorder Market Size Market Share by Application (2019-2024)
3 Attention Deficit Hyperactivity Disorder Market Size by Player
3.1 Attention Deficit Hyperactivity Disorder Market Size Market Share by Players
3.1.1 Global Attention Deficit Hyperactivity Disorder Revenue by Players (2019-2024)
3.1.2 Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Players (2019-2024)
3.2 Global Attention Deficit Hyperactivity Disorder Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Attention Deficit Hyperactivity Disorder by Regions
4.1 Attention Deficit Hyperactivity Disorder Market Size by Regions (2019-2024)
4.2 Americas Attention Deficit Hyperactivity Disorder Market Size Growth (2019-2024)
4.3 APAC Attention Deficit Hyperactivity Disorder Market Size Growth (2019-2024)
4.4 Europe Attention Deficit Hyperactivity Disorder Market Size Growth (2019-2024)
4.5 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size Growth (2019-2024)
5 Americas
5.1 Americas Attention Deficit Hyperactivity Disorder Market Size by Country (2019-2024)
5.2 Americas Attention Deficit Hyperactivity Disorder Market Size by Type (2019-2024)
5.3 Americas Attention Deficit Hyperactivity Disorder Market Size by Application (2019-2024)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Attention Deficit Hyperactivity Disorder Market Size by Region (2019-2024)
6.2 APAC Attention Deficit Hyperactivity Disorder Market Size by Type (2019-2024)
6.3 APAC Attention Deficit Hyperactivity Disorder Market Size by Application (2019-2024)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Attention Deficit Hyperactivity Disorder by Country (2019-2024)
7.2 Europe Attention Deficit Hyperactivity Disorder Market Size by Type (2019-2024)
7.3 Europe Attention Deficit Hyperactivity Disorder Market Size by Application (2019-2024)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Attention Deficit Hyperactivity Disorder by Region (2019-2024)
8.2 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Type (2019-2024)
8.3 Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Application (2019-2024)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Attention Deficit Hyperactivity Disorder Market Forecast
10.1 Global Attention Deficit Hyperactivity Disorder Forecast by Regions (2025-2030)
10.1.1 Global Attention Deficit Hyperactivity Disorder Forecast by Regions (2025-2030)
10.1.2 Americas Attention Deficit Hyperactivity Disorder Forecast
10.1.3 APAC Attention Deficit Hyperactivity Disorder Forecast
10.1.4 Europe Attention Deficit Hyperactivity Disorder Forecast
10.1.5 Middle East & Africa Attention Deficit Hyperactivity Disorder Forecast
10.2 Americas Attention Deficit Hyperactivity Disorder Forecast by Country (2025-2030)
10.2.1 United States Attention Deficit Hyperactivity Disorder Market Forecast
10.2.2 Canada Attention Deficit Hyperactivity Disorder Market Forecast
10.2.3 Mexico Attention Deficit Hyperactivity Disorder Market Forecast
10.2.4 Brazil Attention Deficit Hyperactivity Disorder Market Forecast
10.3 APAC Attention Deficit Hyperactivity Disorder Forecast by Region (2025-2030)
10.3.1 China Attention Deficit Hyperactivity Disorder Market Forecast
10.3.2 Japan Attention Deficit Hyperactivity Disorder Market Forecast
10.3.3 Korea Attention Deficit Hyperactivity Disorder Market Forecast
10.3.4 Southeast Asia Attention Deficit Hyperactivity Disorder Market Forecast
10.3.5 India Attention Deficit Hyperactivity Disorder Market Forecast
10.3.6 Australia Attention Deficit Hyperactivity Disorder Market Forecast
10.4 Europe Attention Deficit Hyperactivity Disorder Forecast by Country (2025-2030)
10.4.1 Germany Attention Deficit Hyperactivity Disorder Market Forecast
10.4.2 France Attention Deficit Hyperactivity Disorder Market Forecast
10.4.3 UK Attention Deficit Hyperactivity Disorder Market Forecast
10.4.4 Italy Attention Deficit Hyperactivity Disorder Market Forecast
10.4.5 Russia Attention Deficit Hyperactivity Disorder Market Forecast
10.5 Middle East & Africa Attention Deficit Hyperactivity Disorder Forecast by Region (2025-2030)
10.5.1 Egypt Attention Deficit Hyperactivity Disorder Market Forecast
10.5.2 South Africa Attention Deficit Hyperactivity Disorder Market Forecast
10.5.3 Israel Attention Deficit Hyperactivity Disorder Market Forecast
10.5.4 Turkey Attention Deficit Hyperactivity Disorder Market Forecast
10.5.5 GCC Countries Attention Deficit Hyperactivity Disorder Market Forecast
10.6 Global Attention Deficit Hyperactivity Disorder Forecast by Type (2025-2030)
10.7 Global Attention Deficit Hyperactivity Disorder Forecast by Application (2025-2030)
11 Key Players Analysis
11.1 Eli Lilly
11.1.1 Eli Lilly Company Information
11.1.2 Eli Lilly Attention Deficit Hyperactivity Disorder Product Offered
11.1.3 Eli Lilly Attention Deficit Hyperactivity Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.1.4 Eli Lilly Main Business Overview
11.1.5 Eli Lilly Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Attention Deficit Hyperactivity Disorder Product Offered
11.2.3 Novartis Attention Deficit Hyperactivity Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Takeda
11.3.1 Takeda Company Information
11.3.2 Takeda Attention Deficit Hyperactivity Disorder Product Offered
11.3.3 Takeda Attention Deficit Hyperactivity Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.3.4 Takeda Main Business Overview
11.3.5 Takeda Latest Developments
11.4 Pfizer
11.4.1 Pfizer Company Information
11.4.2 Pfizer Attention Deficit Hyperactivity Disorder Product Offered
11.4.3 Pfizer Attention Deficit Hyperactivity Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.4.4 Pfizer Main Business Overview
11.4.5 Pfizer Latest Developments
11.5 GlaxoSmithKline
11.5.1 GlaxoSmithKline Company Information
11.5.2 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Product Offered
11.5.3 GlaxoSmithKline Attention Deficit Hyperactivity Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.5.4 GlaxoSmithKline Main Business Overview
11.5.5 GlaxoSmithKline Latest Developments
11.6 Mallinckrodt
11.6.1 Mallinckrodt Company Information
11.6.2 Mallinckrodt Attention Deficit Hyperactivity Disorder Product Offered
11.6.3 Mallinckrodt Attention Deficit Hyperactivity Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.6.4 Mallinckrodt Main Business Overview
11.6.5 Mallinckrodt Latest Developments
11.7 Hisamitsu
11.7.1 Hisamitsu Company Information
11.7.2 Hisamitsu Attention Deficit Hyperactivity Disorder Product Offered
11.7.3 Hisamitsu Attention Deficit Hyperactivity Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.7.4 Hisamitsu Main Business Overview
11.7.5 Hisamitsu Latest Developments
11.8 Johnson & Johnson
11.8.1 Johnson & Johnson Company Information
11.8.2 Johnson & Johnson Attention Deficit Hyperactivity Disorder Product Offered
11.8.3 Johnson & Johnson Attention Deficit Hyperactivity Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.8.4 Johnson & Johnson Main Business Overview
11.8.5 Johnson & Johnson Latest Developments
11.9 Purdue Parma
11.9.1 Purdue Parma Company Information
11.9.2 Purdue Parma Attention Deficit Hyperactivity Disorder Product Offered
11.9.3 Purdue Parma Attention Deficit Hyperactivity Disorder Revenue, Gross Margin and Market Share (2019-2024)
11.9.4 Purdue Parma Main Business Overview
11.9.5 Purdue Parma Latest Developments
12 Research Findings and Conclusion

Table 1. Attention Deficit Hyperactivity Disorder Market Size CAGR by Region (2019 VS 2023 VS 2030) & ($ Millions)
Table 2. Major Players of Stimulants Drugs
Table 3. Major Players of Non-stimulants Drugs
Table 4. Attention Deficit Hyperactivity Disorder Market Size CAGR by Type (2019 VS 2023 VS 2030) & ($ Millions)
Table 5. Global Attention Deficit Hyperactivity Disorder Market Size by Type (2019-2024) & ($ Millions)
Table 6. Global Attention Deficit Hyperactivity Disorder Market Size Market Share by Type (2019-2024)
Table 7. Attention Deficit Hyperactivity Disorder Market Size CAGR by Application (2019 VS 2023 VS 2030) & ($ Millions)
Table 8. Global Attention Deficit Hyperactivity Disorder Market Size by Application (2019-2024) & ($ Millions)
Table 9. Global Attention Deficit Hyperactivity Disorder Market Size Market Share by Application (2019-2024)
Table 10. Global Attention Deficit Hyperactivity Disorder Revenue by Players (2019-2024) & ($ Millions)
Table 11. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Player (2019-2024)
Table 12. Attention Deficit Hyperactivity Disorder Key Players Head office and Products Offered
Table 13. Attention Deficit Hyperactivity Disorder Concentration Ratio (CR3, CR5 and CR10) & (2022-2024)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Attention Deficit Hyperactivity Disorder Market Size by Regions 2019-2024 & ($ Millions)
Table 17. Global Attention Deficit Hyperactivity Disorder Market Size Market Share by Regions (2019-2024)
Table 18. Global Attention Deficit Hyperactivity Disorder Revenue by Country/Region (2019-2024) & ($ millions)
Table 19. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Country/Region (2019-2024)
Table 20. Americas Attention Deficit Hyperactivity Disorder Market Size by Country (2019-2024) & ($ Millions)
Table 21. Americas Attention Deficit Hyperactivity Disorder Market Size Market Share by Country (2019-2024)
Table 22. Americas Attention Deficit Hyperactivity Disorder Market Size by Type (2019-2024) & ($ Millions)
Table 23. Americas Attention Deficit Hyperactivity Disorder Market Size Market Share by Type (2019-2024)
Table 24. Americas Attention Deficit Hyperactivity Disorder Market Size by Application (2019-2024) & ($ Millions)
Table 25. Americas Attention Deficit Hyperactivity Disorder Market Size Market Share by Application (2019-2024)
Table 26. APAC Attention Deficit Hyperactivity Disorder Market Size by Region (2019-2024) & ($ Millions)
Table 27. APAC Attention Deficit Hyperactivity Disorder Market Size Market Share by Region (2019-2024)
Table 28. APAC Attention Deficit Hyperactivity Disorder Market Size by Type (2019-2024) & ($ Millions)
Table 29. APAC Attention Deficit Hyperactivity Disorder Market Size Market Share by Type (2019-2024)
Table 30. APAC Attention Deficit Hyperactivity Disorder Market Size by Application (2019-2024) & ($ Millions)
Table 31. APAC Attention Deficit Hyperactivity Disorder Market Size Market Share by Application (2019-2024)
Table 32. Europe Attention Deficit Hyperactivity Disorder Market Size by Country (2019-2024) & ($ Millions)
Table 33. Europe Attention Deficit Hyperactivity Disorder Market Size Market Share by Country (2019-2024)
Table 34. Europe Attention Deficit Hyperactivity Disorder Market Size by Type (2019-2024) & ($ Millions)
Table 35. Europe Attention Deficit Hyperactivity Disorder Market Size Market Share by Type (2019-2024)
Table 36. Europe Attention Deficit Hyperactivity Disorder Market Size by Application (2019-2024) & ($ Millions)
Table 37. Europe Attention Deficit Hyperactivity Disorder Market Size Market Share by Application (2019-2024)
Table 38. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Region (2019-2024) & ($ Millions)
Table 39. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size Market Share by Region (2019-2024)
Table 40. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Type (2019-2024) & ($ Millions)
Table 41. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size Market Share by Type (2019-2024)
Table 42. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size by Application (2019-2024) & ($ Millions)
Table 43. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size Market Share by Application (2019-2024)
Table 44. Key Market Drivers & Growth Opportunities of Attention Deficit Hyperactivity Disorder
Table 45. Key Market Challenges & Risks of Attention Deficit Hyperactivity Disorder
Table 46. Key Industry Trends of Attention Deficit Hyperactivity Disorder
Table 47. Global Attention Deficit Hyperactivity Disorder Market Size Forecast by Regions (2025-2030) & ($ Millions)
Table 48. Global Attention Deficit Hyperactivity Disorder Market Size Market Share Forecast by Regions (2025-2030)
Table 49. Global Attention Deficit Hyperactivity Disorder Market Size Forecast by Type (2025-2030) & ($ Millions)
Table 50. Global Attention Deficit Hyperactivity Disorder Market Size Forecast by Application (2025-2030) & ($ Millions)
Table 51. Eli Lilly Details, Company Type, Attention Deficit Hyperactivity Disorder Area Served and Its Competitors
Table 52. Eli Lilly Attention Deficit Hyperactivity Disorder Product Offered
Table 53. Eli Lilly Attention Deficit Hyperactivity Disorder Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 54. Eli Lilly Main Business
Table 55. Eli Lilly Latest Developments
Table 56. Novartis Details, Company Type, Attention Deficit Hyperactivity Disorder Area Served and Its Competitors
Table 57. Novartis Attention Deficit Hyperactivity Disorder Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Attention Deficit Hyperactivity Disorder Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 60. Novartis Latest Developments
Table 61. Takeda Details, Company Type, Attention Deficit Hyperactivity Disorder Area Served and Its Competitors
Table 62. Takeda Attention Deficit Hyperactivity Disorder Product Offered
Table 63. Takeda Main Business
Table 64. Takeda Attention Deficit Hyperactivity Disorder Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 65. Takeda Latest Developments
Table 66. Pfizer Details, Company Type, Attention Deficit Hyperactivity Disorder Area Served and Its Competitors
Table 67. Pfizer Attention Deficit Hyperactivity Disorder Product Offered
Table 68. Pfizer Main Business
Table 69. Pfizer Attention Deficit Hyperactivity Disorder Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 70. Pfizer Latest Developments
Table 71. GlaxoSmithKline Details, Company Type, Attention Deficit Hyperactivity Disorder Area Served and Its Competitors
Table 72. GlaxoSmithKline Attention Deficit Hyperactivity Disorder Product Offered
Table 73. GlaxoSmithKline Main Business
Table 74. GlaxoSmithKline Attention Deficit Hyperactivity Disorder Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 75. GlaxoSmithKline Latest Developments
Table 76. Mallinckrodt Details, Company Type, Attention Deficit Hyperactivity Disorder Area Served and Its Competitors
Table 77. Mallinckrodt Attention Deficit Hyperactivity Disorder Product Offered
Table 78. Mallinckrodt Main Business
Table 79. Mallinckrodt Attention Deficit Hyperactivity Disorder Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 80. Mallinckrodt Latest Developments
Table 81. Hisamitsu Details, Company Type, Attention Deficit Hyperactivity Disorder Area Served and Its Competitors
Table 82. Hisamitsu Attention Deficit Hyperactivity Disorder Product Offered
Table 83. Hisamitsu Main Business
Table 84. Hisamitsu Attention Deficit Hyperactivity Disorder Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 85. Hisamitsu Latest Developments
Table 86. Johnson & Johnson Details, Company Type, Attention Deficit Hyperactivity Disorder Area Served and Its Competitors
Table 87. Johnson & Johnson Attention Deficit Hyperactivity Disorder Product Offered
Table 88. Johnson & Johnson Main Business
Table 89. Johnson & Johnson Attention Deficit Hyperactivity Disorder Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 90. Johnson & Johnson Latest Developments
Table 91. Purdue Parma Details, Company Type, Attention Deficit Hyperactivity Disorder Area Served and Its Competitors
Table 92. Purdue Parma Attention Deficit Hyperactivity Disorder Product Offered
Table 93. Purdue Parma Main Business
Table 94. Purdue Parma Attention Deficit Hyperactivity Disorder Revenue ($ million), Gross Margin and Market Share (2019-2024)
Table 95. Purdue Parma Latest Developments
List of

Figure 1. Attention Deficit Hyperactivity Disorder Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Attention Deficit Hyperactivity Disorder Market Size Growth Rate 2019-2030 ($ Millions)
Figure 6. Attention Deficit Hyperactivity Disorder Sales by Geographic Region (2019, 2023 & 2030) & ($ millions)
Figure 7. Attention Deficit Hyperactivity Disorder Sales Market Share by Country/Region (2023)
Figure 8. Attention Deficit Hyperactivity Disorder Sales Market Share by Country/Region (2019, 2023 & 2030)
Figure 9. Global Attention Deficit Hyperactivity Disorder Market Size Market Share by Type in 2023
Figure 10. Attention Deficit Hyperactivity Disorder in Pediatric
Figure 11. Global Attention Deficit Hyperactivity Disorder Market: Pediatric (2019-2024) & ($ Millions)
Figure 12. Attention Deficit Hyperactivity Disorder in Adolescent
Figure 13. Global Attention Deficit Hyperactivity Disorder Market: Adolescent (2019-2024) & ($ Millions)
Figure 14. Attention Deficit Hyperactivity Disorder in Adults
Figure 15. Global Attention Deficit Hyperactivity Disorder Market: Adults (2019-2024) & ($ Millions)
Figure 16. Global Attention Deficit Hyperactivity Disorder Market Size Market Share by Application in 2023
Figure 17. Global Attention Deficit Hyperactivity Disorder Revenue Market Share by Player in 2023
Figure 18. Global Attention Deficit Hyperactivity Disorder Market Size Market Share by Regions (2019-2024)
Figure 19. Americas Attention Deficit Hyperactivity Disorder Market Size 2019-2024 ($ Millions)
Figure 20. APAC Attention Deficit Hyperactivity Disorder Market Size 2019-2024 ($ Millions)
Figure 21. Europe Attention Deficit Hyperactivity Disorder Market Size 2019-2024 ($ Millions)
Figure 22. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size 2019-2024 ($ Millions)
Figure 23. Americas Attention Deficit Hyperactivity Disorder Value Market Share by Country in 2023
Figure 24. United States Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 25. Canada Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 26. Mexico Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 27. Brazil Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 28. APAC Attention Deficit Hyperactivity Disorder Market Size Market Share by Region in 2023
Figure 29. APAC Attention Deficit Hyperactivity Disorder Market Size Market Share by Type in 2023
Figure 30. APAC Attention Deficit Hyperactivity Disorder Market Size Market Share by Application in 2023
Figure 31. China Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 32. Japan Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 33. Korea Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 34. Southeast Asia Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 35. India Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 36. Australia Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 37. Europe Attention Deficit Hyperactivity Disorder Market Size Market Share by Country in 2023
Figure 38. Europe Attention Deficit Hyperactivity Disorder Market Size Market Share by Type (2019-2024)
Figure 39. Europe Attention Deficit Hyperactivity Disorder Market Size Market Share by Application (2019-2024)
Figure 40. Germany Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 41. France Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 42. UK Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 43. Italy Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 44. Russia Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 45. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size Market Share by Region (2019-2024)
Figure 46. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size Market Share by Type (2019-2024)
Figure 47. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size Market Share by Application (2019-2024)
Figure 48. Egypt Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 49. South Africa Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 50. Israel Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 51. Turkey Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 52. GCC Country Attention Deficit Hyperactivity Disorder Market Size Growth 2019-2024 ($ Millions)
Figure 53. Americas Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 54. APAC Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 55. Europe Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 56. Middle East & Africa Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 57. United States Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 58. Canada Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 59. Mexico Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 60. Brazil Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 61. China Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 62. Japan Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 63. Korea Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 64. Southeast Asia Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 65. India Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 66. Australia Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 67. Germany Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 68. France Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 69. UK Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 70. Italy Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 71. Russia Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 72. Spain Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 73. Egypt Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 74. South Africa Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 75. Israel Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 76. Turkey Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 77. GCC Countries Attention Deficit Hyperactivity Disorder Market Size 2025-2030 ($ Millions)
Figure 78. Global Attention Deficit Hyperactivity Disorder Market Size Market Share Forecast by Type (2025-2030)
Figure 79. Global Attention Deficit Hyperactivity Disorder Market Size Market Share Forecast by Application (2025-2030)

Related Reports

One individual can access, store, display, or archive the report in Excel format but cannot print, copy, or share it. Use is confidential and internal only. License information

One individual can access, store, display, or archive the report in PDF format but cannot print, copy, or share it. Use is confidential and internal only. License information

Up to 10 employees in one region can store, display, duplicate, and archive the report for internal use. Use is confidential and printable. License information

All employees globally can access, print, copy, and cite data externally (with attribution to Bonafide Research). License information

Safe and Secure SSL Encrypted